MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

By

MassDevice.com Personnel MovesCardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO.

Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) and General Surgical Innovations (acquired by U.S. Surgical for $100 million in 1999).

Cardiac Dimensions is developing the Carillon mitral valve, which is designed to treat functional mitral regurgitation. In March, the Kirkland, Wash.-based company raised a $15 million round. Carillon won CE Mark approval in the European Union in 2011.

“With more than 33 years of medical device experience and a proven track record of success leading both private and public companies, Greg will be instrumental in guiding the future strategic direction of Cardiac Dimensions,” said Jan Garfinkle, member of Cardiac Dimensions’ Board of Directors. “Based on his extensive knowledge of the interventional cardiology space, we believe he is the ideal choice to take Cardiac Dimensions to the next level.”

“Cardiac Dimensions has an innovative platform that is designed to address the unmet needs of heart failure patients and the related condition of FMR,” Casciaro added. “The clinical data available for this therapy have demonstrated that it benefits patients significantly and, we believe, holds incredible promise for the future. I am excited to lead this talented team forward as we increase access to the therapy through continued global commercialization and expanded clinical work.”

 Ex-Sen. Harkin joins Masimo’s board
Masimo (NSDQ:MASI)
said it added former Sen. Tom Harkin to its board of directors. Harkin, who retired in January, served 5 terms in the Senate.
Read more

 Grifols plans family succession
Grifols (NSDQ:GRFS) chairman & CEO Víctor Grifols is stepping down, to be replaced by his brother, Raimon Grifols, and son Víctor Grifols, effective January 2017.
Read more

 Femasys names Creech as CFO
Femasys said it named Todd Creech, the ex-finance chief at ZS Pharma, to be its new CFO.
Read more

 Cellnovo’s new CTO is Sorin vet Masoud
Cellnovo said it appointed former Sorin Group (BIT:SRN) R&D executive Javaid Masoud to be its new chief technology officer.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Medtronic hiring Walmart exec to run its supply chain
    Medtronic (NYSE:MDT) CEO Geoff Martha announced that the company is appointing Greg Smith as EVP of global operations and supply chain. In a LinkedIn post today, Martha wrote: “I’m pleased to share that Greg Smith, Executive Vice President of U.S. Supply Chain for Walmart, is joining Medtronic on April 5 as Executive Vice President of… […]
  • Philips and Disney want to make MRIs easier for children: Here’s how
    Royal Philips (NYSE:PHG) announced today that it is teaming up with Disney to test the effects of custom-made animation to create a relaxing atmosphere for young patients. Amsterdam-based Philips will collaborate with The Walt Disney Company EMEA to see whether the animation, including specially-made Disney stories within Philips’ Ambient Experience, creates a relaxing atmosphere to improve… […]
  • Origami Surgical gains FDA clearance for robotic suturing devices
    Origami Surgical today announced that the FDA has granted 510(k) clearance for three new types of sutures for its StitchKit robotic surgery platform. The company describes StitchKit as a patented suture delivery and retrieval system designed so sutures are efficiently inserted and needles are safely removed from the surgical field. StitchKit also allows the robotic… […]
  • NAMSA acquires American Preclinical
    Contract research organization NAMSA today announced its acquisition of Minneapolis-based American Preclinical Services (APS). This purchase follows NAMSA’s acquisition of New York-based Syntactx, a clinical research services CRO, in January. The acquisition will provide NAMSA customers with a broader range of laboratory models and analysis tools, including innovative surgical instrumentation and several state-of-the-art catheterization labs,… […]
  • 5 reasons Medtronic’s CEO is optimistic about the future
    Nearly a year after Geoff Martha took over the corner office at Medtronic, the world’s largest medical device company is transforming. In a recent interview with our DeviceTalks Weekly podcast, Martha detailed Medtronic‘s major reorganization, its shift in corporate culture and more. Martha was also highly pleased about Medtronic’s recent Q3 earnings results. Here are… […]
  • Medtronic is changing a lot: Here’s what you need to know
    CEO Geoff Martha says Medtronic‘s ongoing corporate restructuring will position the company to compete better with medical device rivals, freeing the front-line forces from earlier entanglements. But the change will also create new opportunities for Medtronic employees at the company and elsewhere. In a far-ranging interview with the DeviceTalks Weekly podcast, Martha reviewed the company’s… […]
  • Pharma’s been slow to adopt Industry 4.0 — but that could change
    The pharma industry has been relatively slow to embrace concepts such as Industry 4.0, but COVID-19 is serving as a catalyst for sweeping changes within the industry. The philosophy has roots in a German framework that prioritizes digitization to drive manufacturing efficiency, promising that cyber-physical systems will usher in the next industrial revolution. The Industry… […]
  • Ambu single-use endoscope wins Frost & Sullivan innovation award
    Frost & Sullivan today announced that it awarded Ambu with a 2021 Global New Product Innovation Award. Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be… […]
  • Could this hydrogel repair a broken heart?
    European researchers have developed an injectable hydrogel that could help repair and prevent further heart muscle damage after a heart attack. The therapeutic effect of multiple injections of this hydrogel into the cardiac tissue was assessed during the first preclinical study of its kind, demonstrating its efficacy for cardiac tissue remodeling following a heart attack,… […]
  • How EtO plants can avoid lawsuits, cope with stricter regulation
    If EtO industry actors take certain targeted steps now, they can minimize legal exposure, more efficiently manage litigation and be better situated for compliance once new federal regulations are established. Karen Cullinane, Goldberg Segalla The use of ethylene oxide (EtO) to sterilize medical devices came under renewed scrutiny after the Environmental Protection Agency concluded in… […]
  • FDA authorizes Q-Collar to help protect athletes’ brains
    The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial… […]